EUVIMEDEUVIMED entdecken
Crossref

A High-Throughput Chemical Proteomic Approach for Profiling Serum CA19-9 Protein Carriers and Their Characterization in Patients with Elevated CA19-9 Levels

Jin Chen iD, Yuxun Lv, Hanshi Wang iD, Ziang Wu, An He, Yifei Liu, Yanpei Yang, Weina Gao, Ruilian Xu, Ruijun Tian iD

Analytical Chemistry · 10.11.2026 · 98 (44) · 30718-30729

DOI: 10.1021/acs.analchem.6c03878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 13.10.2026. Verfasst von Jin Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Center for Molecular Diagnosis and Therapy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian362000, China. Hauptthemen laut MEDLINE: Proteomics, CA-19-9 Antigen, High-Throughput Screening Assays, Biomarkers, Tumor. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China (NSFC), Joint Funds for the Innovation of Science and Technology in Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the carbohydrate biomarker CA19-9 is widely used for cancer screening, its diagnostic specificity is severely compromised by false-positive elevations in benign inflammatory conditions. Characterizing specific CA19-9 protein carriers provides a promising alternative, yet high-throughput, micro-volume profiling directly from serum remains a challenge. Here, we present a 96-well chemical proteomic platform for the high-throughput profiling of CA19-9-modified proteins. Utilizing a tailored trifunctional chemical probe, photo-activated covalent crosslinking between anti-CA19-9 antibodies and target carriers enables high-stringency enrichment within streptavidin-coated microplates. The workflow identified 509 carriers in cancer cell lines and achieved highly sensitive quantification of established targets, including CD44, LGALS3BP, and mucin family, using as little as 10 μL serum. Notably, this represents the first mass spectrometry-based direct identification of mucin family in peripheral serum. In a clinical cohort of 91 hyper-CA19-9 individuals, CA19-9-modified CD44 was enriched in healthy controls, whereas CA19-9-modified MUC5B was significantly elevated in benign lesions over colorectal cancer (CRC), validated by ELISA across two independent cohorts with AUCs 0.715 and 0.756. Integrating the protein carrier dataset into a random forest machine learning classifier effectively discriminated CRC from benign lesions with an AUC of 0.864. Furthermore, comparative sub-analysis resolved a critical clinical dilemma by identifying 59 upregulated protein carriers in pancreatic ductal adenocarcinoma relative to benign gallstone-induced cholangitis. Overall, this 96-well chemical proteomic strategy enables parallelized isolation of CA19-9 modified proteins from low-volume samples, establishing a reproducible and scalable tool for the differential profiling of clinically relevant carbohydrate antigen carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsCA-19-9 AntigenHigh-Throughput Screening AssaysBiomarkers, TumorHumansCell Line, TumorHyaluronan Receptors

Stichwörter der Autor:innen

CA19-9glycosylationprotein carrierserumtri-functional probe

Substanzen

CA-19-9 AntigenBiomarkers, TumorHyaluronan Receptors

Autor:innen und Institutionen

  • Clinical Center for Molecular Diagnosis and Therapy, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian362000, China.
  • The School of Pharmacy, Fujian Medical University, Fuzhou, Fujian350122, China.
  • Department of Orthopedics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian362000, China.
  • Department of Chemistry and Research Center for Chemical Biology and Omics Analysis, College of Science, Southern University of Science and Technology, Shenzhen518055, China.
  • Shenzhen Key Laboratory of Functional Proteomics, Southern University of Science and Technology, Shenzhen518055, China.
  • Department of Oncology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen518020, China.

ORCID-Profile: Jin Chen, Hanshi Wang, Ruijun Tian

Förderung

  • National Science and Technology Major Project
  • National Natural Science Foundation of China (NSFC)
  • Joint Funds for the Innovation of Science and Technology in Fujian Province
  • Young and Middle-aged Backbone Personnel Training Project of the Health System in Fujian Province
  • National Key R&D Program of China
  • Shenzhen Innovation of Science and Technology Commission

Zitieren

APA

Chen, J., Lv, Y., Wang, H., Wu, Z., He, A., Liu, Y., Yang, Y., Gao, W., Xu, R., & Tian, R. (2026). A High-Throughput Chemical Proteomic Approach for Profiling Serum CA19-9 Protein Carriers and Their Characterization in Patients with Elevated CA19-9 Levels. Analytical Chemistry, 98(44), 30718-30729. https://doi.org/10.1021/acs.analchem.6c03878

Vancouver

Chen J, Lv Y, Wang H, Wu Z, He A, Liu Y, et al. A High-Throughput Chemical Proteomic Approach for Profiling Serum CA19-9 Protein Carriers and Their Characterization in Patients with Elevated CA19-9 Levels. Analytical Chemistry. 2026;98(44):30718-30729. doi:10.1021/acs.analchem.6c03878

BibTeX
@article{Chen2026,
  author = {Chen, Jin and Lv, Yuxun and Wang, Hanshi and Wu, Ziang and He, An and Liu, Yifei and Yang, Yanpei and Gao, Weina and Xu, Ruilian and Tian, Ruijun},
  title = {A High-Throughput Chemical Proteomic Approach for Profiling Serum CA19-9 Protein Carriers and Their Characterization in Patients with Elevated CA19-9 Levels},
  journal = {Analytical Chemistry},
  year = {2026},
  volume = {98},
  number = {44},
  pages = {30718--30729},
  doi = {10.1021/acs.analchem.6c03878}
}
Kostenlos starten →